top of page
Executive Spotlights

Bolt Biotherapeutics Appoints Willie Quinn as Chief Executive Officer

Redwood City, CA, May 14, 2024 (Globe Newswire) -- Bolt Biotherapeutics, a biopharmaceutical firm headquartered in Redwood City, California, unveiled its financial performance for the first quarter of 2024 while concurrently announcing a strategic realignment and leadership reshuffle. Emphasizing a shift in focus, the company delineated its intent to prioritize its pioneering agonist antibody targeting Dectin-2 and its cutting-edge Boltbody™ ISAC programs, alongside continued support for partnerships with Genmab and Toray. This strategic pivot also includes the appointment of Willie Quinn as Chief Executive Office.


Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e

Comments


Life Science Headlines
bottom of page